
Bill Muller, MD, PhD, chair of pathology, is being given the American Society for Investigative Pathology’s most prestigious honor during the Experimental Biology Meeting this April in Boston.

New research by Julie Kim, PhD, Susy Y. Hung Research Professor, suggests that the combination of a synthetic hormone and a signaling inhibitor may provide new treatment options for women diagnosed with endometrial cancer.